InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51
United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
Huda Y Zoghbi
3 Nov 2026
Director
Sold after exercise
500
$971.06
$485.53K
Huda Y Zoghbi
3 Nov 2026
Director
Sold after exercise
6,939
$970.42
$6.73M
Joseph J Larosa
2 Nov 2026
EVP General Counsel and Secret
Sold after exercise
527
$966.11
$509.14K
Joseph J Larosa
2 Nov 2026
EVP General Counsel and Secret
Sold after exercise
3,939
$965.41
$3.80M
Christine A Poon
2 Nov 2026
Director
Sold after exercise
201
$971.31
$195.23K
Christine A Poon
2 Nov 2026
Director
Sold after exercise
937
$970.51
$909.37K
Christine A Poon
2 Nov 2026
Director
Sold after exercise
3,203
$969.50
$3.11M
Christine A Poon
2 Nov 2026
Director
Sold after exercise
2,499
$968.58
$2.42M
Christine A Poon
2 Nov 2026
Director
Sold after exercise
772
$967.38
$746.82K
Christine A Poon
2 Nov 2026
Director
Sold after exercise
218
$966.74
$210.75K
George L Sing
2 Nov 2026
Director
Sold after exercise
200
$970.18
$194.04K
George L Sing
2 Nov 2026
Director
Sold after exercise
1,040
$967.07
$1.01M
George L Sing
2 Nov 2026
Director
Sold after exercise
1,522
$966.27
$1.47M
George L Sing
2 Nov 2026
Director
Sold after exercise
7,073
$965.38
$6.83M
George L Sing
2 Nov 2026
Director
Sold after exercise
2,670
$964.57
$2.58M
George L Sing
2 Nov 2026
Director
Sold after exercise
4,338
$963.47
$4.18M
George L Sing
2 Nov 2026
Director
Sold after exercise
2,522
$962.61
$2.43M
George L Sing
2 Nov 2026
Director
Sold after exercise
540
$961.85
$519.40K
George L Sing
2 Nov 2026
Director
Sold after exercise
1,224
$960.57
$1.18M
Michael S Brown
30 Oct 2026
Director
Sold after exercise
1,929
$875.00
$1.69M
Kathryn Guarini
30 Oct 2026
Director
Sold after exercise
400
$900.00
$360.00K
Kathryn Guarini
2 Sep 2026
Director
Sold after exercise
400
$850.00
$340.00K
Huda Y Zoghbi
10 Aug 2026
Director
Sold after exercise
800
$800.00
$640.00K
Kathryn Guarini
10 Aug 2026
Director
Sold after exercise
400
$800.00
$320.00K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
4
$790.00
$3.16K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
56
$785.61
$43.99K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
160
$784.45
$125.51K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
220
$783.29
$172.32K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
298
$782.10
$233.07K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
209
$781.28
$163.29K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
331
$780.45
$258.33K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
208
$779.55
$162.15K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
53
$778.47
$41.26K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
50
$775.50
$38.78K
Huda Y Zoghbi
19 Feb 2026
Director
Sold after exercise
49
$774.68
$37.96K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
53
$785.72
$41.64K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
1
$784.66
$784.66
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
144
$783.23
$112.79K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
37
$782.67
$28.96K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
26
$781.37
$20.32K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
75
$780.06
$58.50K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
205
$779.56
$159.81K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
563
$778.35
$438.21K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
391
$777.51
$304.01K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
521
$776.43
$404.52K
Jason Pitofsky
9 Feb 2026
SVP Controller
Sold after exercise
20
$775.95
$15.52K
Bonnie L Bassler
7 Jan 2026
Director
Sold after exercise
1,500
$800.00
$1.20M
Bonnie L Bassler
20 Nov 2025
Director
Sold after exercise
760
$750.00
$570.00K
Show all 135 transactions →

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 78
Sales straight out of an exercise 48
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 932,353
History held since 3 Oct 2006